表紙
市場調查報告書

關節鏡檢查設備市場 - 成長,趨勢,及預測(2019年 - 2024年)

Arthroscopy Devices Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871442
出版日期 內容資訊 英文 116 Pages
商品交期: 2-3個工作天內
價格
Back to Top
關節鏡檢查設備市場 - 成長,趨勢,及預測(2019年 - 2024年) Arthroscopy Devices Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 116 Pages
簡介

全球關節鏡檢查設備市場在2019年∼2024年間,預測將以6%的年複合成長率成長。市場成長要素,有運動傷害的發生率增加,老年人口的增加,及關節鏡植入的技術進步等。

本報告提供關節鏡檢查設備市場的相關調查,市場概況和成長要素、阻礙因素,各用途、產品、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 運動傷害的發生率增加
    • 老年人口的增加
    • 關節鏡下關節移植的技術進步
  • 市場阻礙因素
    • 熟練的外科醫生不足
    • 嚴格法規必要條件
    • 高價的關節鏡檢查設備
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業的競爭

第5章 市場區隔

  • 用途
    • 膝關節鏡檢查
    • 胯關節鏡檢查
    • 脊椎關節鏡檢查
    • 肩膀和肘的關節鏡檢查
    • 其他
  • 各產品
    • 關節鏡
    • 關節鏡植入
    • 液體管理系統
    • 無線電頻率(射頻)(RF)系統
    • 可視化系統
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Arthrex Inc.
    • Conmed Corporation
    • Johnson & Johnson
    • Karl Storz GmbH & Co. KG
    • Medtronic Plc.
    • Richard Wolf GmbH
    • Smith & Nephew Plc
    • Stryker Corporation

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 57113

Market Overview

Global Arthroscopy Devices market is expected to witness a CAGR of 6% during the forecast period. Certain factors that are driving the market growth include increasing incidences of sports injuries, rising geriatric population, and technological advancements in arthroscopic implants.

Fractures, strains, sprains, and dislocations are the most common sports injuries. The usual self-treatment recommended for these injuries includes rest, ice, compression, and elevation (RICE). For serious injuries that need more attention, an arthroscopy could be recommended, depending on the situation. Injuries can occur at various places and can be of various types. Some of the common injuries include shoulder, hip, knee, elbow, wrist, or ankle injuries; cartilage tears or ligament injuries; inflammation of the lining of the joints; removal of loose fragments of bone or cartilage that become lodged in a joint; and osteoarthritis caused by cartilage loss in a joint. Some of these may require arthroscopic surgery, as it is helpful in their diagnosis and treatment. According to the US Centers for Disease Control (CDC), participation in organized sports is increasing. Each year, approximately 30 million children and adolescents participate in youth sports in the United States. Out of them, athletes from high schools account for an estimated 2 million injuries, 0.5 million doctor visits, and 30,000 hospitalizations, every year. Also, more than 3.5 million kids under the age of 14 years receive medical treatment for sports injuries, each year. Children between the ages of 5-14 years account for nearly 40% of all sports injuries treated in hospitals. In the United States, injuries associated with participation in sports and recreational activities accounted for 21% of all traumatic brain injuries among children, in 2017. The above-mentioned statistics exhibit an increased number of injuries that require arthroscopy procedures, which is expected to have a positive impact on the market studied.

However, the average standard cost of an outpatient treatment using arthroscopic surgery for complicated tears can cost about USD 7,400-9,000, or even more, depending on the age of the patient, the severity and exact location of the injury, whether related injuries are present, and on the hospital where the procedure is performed. The Agency for Healthcare Research and Quality sponsors a series of medical databases. One such database, namely, Healthcare Cost and Utilization, shows that outpatient arthroscopic surgery typically costs USD 8,970. For insured patients, out-of-pocket costs typically consist of a specialist co-pay, i.e., mostly a hospital co-pay of USD 100 or more, and co-insurance of 10-50% for the procedure, which could reach the yearly out-of-pocket maximum. According to the Kaiser Family Foundation, the average hospital copay is USD 132 for outpatient surgery, and USD 232 for inpatient surgery and the average coinsurance rate is 17-18%. This shows that the average cost of arthroscopic procedures is quite high, and this could lead to people not opting for the procedure. Hence, high cost proves to be a potential restraint for the market.

Scope of the Report

Arthroscopy devices are used to examine the bone joints for specific conditions, such as osteoarthritis, rheumatoid arthritis, tendinitis, and bone tumor. The increase in the prevalence of musculoskeletal disorders due to the rapidly aging population is the prime factor driving the demand for arthroscopy procedures.

Key Market Trends

Knee Arthroscopy is Expected to Hold Significant Market Share in the Application Segment

Degenerative knee disease is a globally occurring phenomenon among the elderly, which is growing in prevalence, due to an increase in the global geriatric population. According to the WHO, approximately 25% of the people older than 50 years experience knee pain from degenerative knee disease. The pain is impairing in nature, and often, a knee replacement procedure is the final and only resort to alleviate pain. Arthroscopic knee surgery for degenerative knee disease is the most common orthopedic procedure in the United States and most other developed countries. CDC estimates indicate that in the United States, healthcare expenditure toward arthroscopic procedures for degenerative knee disease amounted to more than 3 billion USD, in 2015. The demand for knee arthroscopy is increasing globally as well, due to the increasing prevalence of sports injuries, particularly those acquired in contact sports.

North America Dominates the Market and Expected to do Same in the Forecasted Period

There has been a drastic increase in the number of arthroscopies performed in North America in the past two decades. The highest growth has been in knee arthroscopy and hip arthroscopy. According to estimates derived from the Humana Claims database, the number of hip arthroscopies increased by a very high growth rate from 2007 to 2014. The highest incidence was registered by patients belonging to the age group of 35-44 years. The number of hip arthroscopies performed in North America is continuing to increase, along with an increase in the complexity and diversity of procedures. The diversity of procedures is indicative of the advancements in arthroscopy products and the highly active research ecosystem for arthroscopic applications. The increase in arthroscopy procedures in the region is driven by the increasing prevalence of chronic diseases and orthopedic ailments, especially among the aging population of the region. There has also been a drastic increase in the prevalence of sports injuries in North America. This is directly correlated to the increased number of arthroscopy procedures that are being performed in the region.

Competitive Landscape

The global Arthroscopy Devices market is highly competitive and consists of a number of major players. Companies like Arthrex Inc., Conmed Corporation, Johnson & Johnson (DePuy Synthes), Karl Storz GmbH & Co. KG, Medtronic Plc., Richard Wolf GmbH, Smith & Nephew Plc, Stryker Corporation, among others, hold the substantial market share in the Arthroscopy Devices market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Sports Injuries
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancements in Arthroscopic Implants
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Surgeons
    • 4.3.2 Stringent Regulatory Requirements
    • 4.3.3 High Cost of Arthroscopy Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Application
    • 5.1.1 Knee Arthroscopy
    • 5.1.2 Hip Arthroscopy
    • 5.1.3 Spine Arthroscopy
    • 5.1.4 Shoulder and Elbow Arthroscopy
    • 5.1.5 Other Arthroscopy Applications
  • 5.2 Product
    • 5.2.1 Arthroscope
    • 5.2.2 Arthroscopic Implant
    • 5.2.3 Fluid Management System
    • 5.2.4 Radiofrequency (RF) System
    • 5.2.5 Visualization System
    • 5.2.6 Other Products
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Arthrex Inc.
    • 6.1.2 Conmed Corporation
    • 6.1.3 Johnson & Johnson
    • 6.1.4 Karl Storz GmbH & Co. KG
    • 6.1.5 Medtronic Plc.
    • 6.1.6 Richard Wolf GmbH
    • 6.1.7 Smith & Nephew Plc
    • 6.1.8 Stryker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top